+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Preresection transarterial chemoembolization for hepatocellular carcinoma



Preresection transarterial chemoembolization for hepatocellular carcinoma



Indian Journal of Gastroenterology 34(2): 188




(PDF emailed within 0-6 h: $19.90)

Accession: 058609826

Download citation: RISBibTeXText

PMID: 25895047

DOI: 10.1007/s12664-014-0511-x


Related references

Preresection transarterial chemoembolization for hepatocellular carcinoma: an experience with 23 patients. Indian Journal of Gastroenterology 33(5): 432-439, 2015

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma. Hepatic Medicine 8: 69-74, 2016

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma. Bmc Cancer 15: 465, 2016

Hepatic Resection after Initial Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone for the Treatment of Hepatocellular Carcinoma: A Meta-analysis of Observational Studies. Asian Pacific Journal of Cancer Prevention 16(17): 7871-7874, 2016

Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 24(8): 1437-1444, 2009

Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study. Plos One 9(5): E96620, 2015

Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. Journal of Gastroenterology and Hepatology 28(3): 456-463, 2013

Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study. Tumour Biology 36(1): 183-191, 2015

Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization. Abdominal Radiology 42(2): 612-619, 2016

A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 26(11): 1622-1629, 2016

Description of the sagittal alignment of the degenerative human spine. European Spine Journal 27(2): 489-496, 2017

Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma. Radiologia 53(3): 246-253, 2011

Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial. Journal of Hepatology 51(6): 1030-1036, 2010

Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality. Hepatology International 10(6): 883-892, 2016

Improved time to progression for transarterial chemoembolization compared with transarterial embolization for patients with unresectable hepatocellular carcinoma. Clinical Colorectal Cancer 11(3): 185-190, 2013